These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 132382)

  • 41. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of kinetic cooperativity of hexokinase D (glucokinase) by competitive inhibitors. A slow transition model.
    Cárdenas ML; Rabajille E; Niemeyer H
    Eur J Biochem; 1984 Nov; 145(1):163-71. PubMed ID: 6489350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alloxan toxicity in isolated rat hepatocytes and protection by sugars.
    Harman AW; Fischer LJ
    Biochem Pharmacol; 1982 Dec; 31(23):3731-6. PubMed ID: 7159455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of blood glucose in the dimethylthiourea-induced protection against alloxan-induced diabetes.
    Masukawa T; Nakanishi K
    Jpn J Pharmacol; 1994 Sep; 66(1):159-61. PubMed ID: 7861663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of alloxan and anomers of D-glucose on glucose-induced insulin secretion and biosynthesis in vitro.
    Niki A; Niki H; Miwa I; Lin BJ
    Diabetes; 1976 Jul; 25(7):574-9. PubMed ID: 776725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influx of gamma-aminobutyric acid and alpha-aminoisobutyric acid into mouse cerebrum slices incubated in a pyruvate medium with or without added glucose or glucose analogues compared with influx from a glucose medium.
    Cohen SR
    J Neurochem; 1980 Oct; 35(4):1008-12. PubMed ID: 7452287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes.
    Masiello P; Cubeddu TL; Frosina G; Bergamini E
    Diabetologia; 1985 Sep; 28(9):683-6. PubMed ID: 2933287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction.
    Lacković Z; Salković M
    Life Sci; 1990; 46(1):49-54. PubMed ID: 1688991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.
    Szkudelski T
    Physiol Res; 2001; 50(6):537-46. PubMed ID: 11829314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents.
    Yamanouchi T; Akaoka I; Akanuma Y; Akanuma H; Miyashita E
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E423-7. PubMed ID: 2138419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of alloxan on insulin secretion in isolated rat islets perifused in vitro.
    Tomita T; Lacy PE; Natschinsky FM; McDaniel ML
    Diabetes; 1974 Jun; 23(6):517-24. PubMed ID: 4600579
    [No Abstract]   [Full Text] [Related]  

  • 52. Evidence for a single kind of D-glucose binding site on renal brush borders.
    Chertok RJ; Lake S
    Biochim Biophys Acta; 1974 Mar; 339(2):202-9. PubMed ID: 4827850
    [No Abstract]   [Full Text] [Related]  

  • 53. Glucoprivic feeding is impaired by lateral or fourth ventricular alloxan injection.
    Ritter S; Murnane JM; Ladenheim EE
    Am J Physiol; 1982 Sep; 243(3):R312-7. PubMed ID: 6214195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal D cell secretion in alloxan-diabetes: influence by drug and aberrant metabolism.
    Grill V; Efendić S
    Am J Physiol; 1984 Jun; 246(6 Pt 1):E483-92. PubMed ID: 6204535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreatic B cells possess defense mechanisms against cell-specific toxicity.
    Pipeleers D; Van de Winkel M
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5267-71. PubMed ID: 2941762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Structural and enzymatic changes in the islets of the rat pancreas following alloxan and streptozotocin administration].
    Hettwer H; Dahlmann B; Marjanovic SD
    Cell Mol Biol Incl Cyto Enzymol; 1978; 23(4):355-67. PubMed ID: 162617
    [No Abstract]   [Full Text] [Related]  

  • 57. Pancreatic D-cell recognition of D-glucose: studies with D-glucose, D-glyceraldehyde, dihydroxyacetone, D-mannoheptulose, D-fructose, D-galactose, and D-ribose.
    Hermansen K
    Diabetes; 1981 Mar; 30(3):203-10. PubMed ID: 6110600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alloxan diabetogenicity: determinants of potentiation, protection and B-cell selectivity.
    Boquist L
    Diabete Metab; 1989; 15(1):23-9. PubMed ID: 2542107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the mechanism of glucose protection against alloxan toxicity.
    Scheynius A; Täljedal IB
    Diabetologia; 1971 Aug; 7(4):252-5. PubMed ID: 4937446
    [No Abstract]   [Full Text] [Related]  

  • 60. Alloxan cytotoxicity in vitro. Inhibition of rubidium ion pumping in pancreatic beta-cells.
    Idahl LA; Lernmark A; Sehlin J; Täljedal IB
    Biochem J; 1977 Jan; 162(1):9-18. PubMed ID: 192215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.